Literature DB >> 21093733

Childhood periodic syndromes: a population-based study.

Marco A Arruda1, Vincenzo Guidetti, Federica Galli, Regina C A P Albuquerque, Marcelo E Bigal.   

Abstract

The objective of the present study was to estimate the prevalence and relative risk of symptoms suggestive of childhood periodic syndrome in migraine, migraine subtypes, and tension-type headache, relative to control subjects. The target population was all children (age 5-12 years) enrolled in public elementary schools in one Brazilian city (n = 2173). Consent was obtained for 1994 children; analyzable data were available for 1906 children, for a final sample of 1113 children with migraine, tension-type headache, or no headache. Parents were interviewed using validated questionnaires. Headache diagnosis was assigned according to the International Classification of Headache Disorders, 2nd edition. Relative risk of symptoms was drawn by headache categories relative to controls. For episodic migraine, the relative risk of all symptoms except nocturnal enuresis was significantly increased: motion sickness, recurrent limb pain, recurrent abdominal pain, and parasomnias, such as sleep talking, somnambulism, and bruxism. For tension-type headache, only nocturnal enuresis and motion sickness were not more common than in controls. In multivariate analyses, any interictal symptom was independently associated with any headache (P < 0.001), migraine headaches (P < 0.001), and tension-type headaches (P < 0.01). These findings indicate that interictal symptoms suggestive of childhood periodic syndromes are common in the population, and are associated with migraine and specific migraine subtypes, but also with tension-type headache.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21093733     DOI: 10.1016/j.pediatrneurol.2010.06.016

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  11 in total

Review 1.  Migraine and sleep disorders.

Authors:  S Cevoli; G Giannini; V Favoni; G Pierangeli; P Cortelli
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

Review 2.  Headache in school children: prevalence and risk factors.

Authors:  Andreas Straube; Florian Heinen; Friedrich Ebinger; Rüdiger von Kries
Journal:  Dtsch Arztebl Int       Date:  2013-11-29       Impact factor: 5.594

3.  Headache in school age.

Authors:  G Casucci; R Terlizzi; S Cevoli
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

Review 4.  Comorbidity of Migraine.

Authors:  Şebnem Biçakci
Journal:  Noro Psikiyatr Ars       Date:  2013-08-01       Impact factor: 1.339

5.  Incidence and Remission of Parasomnias among Adolescent Children in the Tucson Children's Assessment of Sleep Apnea (TuCASA) Study.

Authors:  Oscar Furet; James L Goodwin; Stuart F Quan
Journal:  Southwest J Pulm Crit Care       Date:  2011-01-01

6.  Community based study of sleep bruxism during early childhood.

Authors:  Salvatore P Insana; David Gozal; Daniel W McNeil; Hawley E Montgomery-Downs
Journal:  Sleep Med       Date:  2012-12-06       Impact factor: 3.492

7.  Why does sleep stop migraine?

Authors:  Marcelo E Bigal; Richard J Hargreaves
Journal:  Curr Pain Headache Rep       Date:  2013-10

Review 8.  Sex and the migraine brain.

Authors:  D Borsook; N Erpelding; A Lebel; C Linnman; R Veggeberg; P E Grant; C Buettner; L Becerra; R Burstein
Journal:  Neurobiol Dis       Date:  2014-03-21       Impact factor: 5.996

9.  Migraine equivalents and related symptoms, psychological profile and headache features: which relationship?

Authors:  Samuela Tarantino; Cristiana De Ranieri; Cecilia Dionisi; Valentina Gagliardi; Alessandro Capuano; Federico Vigevano; Simonetta Gentile; Massimiliano Valeriani
Journal:  J Headache Pain       Date:  2015-06-09       Impact factor: 7.277

Review 10.  Pediatric migraine and episodic syndromes that may be associated with migraine.

Authors:  Daniele Spiri; Victoria Elisa Rinaldi; Luigi Titomanlio
Journal:  Ital J Pediatr       Date:  2014-11-19       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.